Literature DB >> 17087867

Legal aspects of chronic opioid therapy.

Kwai-Tung Chan1, Scott M Fishman.   

Abstract

Although many Americans suffer from undertreated pain, the regulatory and legal environment for the use of opioids in pain relief is currently in a state of flux. The federal government's efforts to curb drug abuse have complicated the use of opioids for pain relief. Recent actions by the US Drug Enforcement Agency have added to an atmosphere of mistrust and confusion and have increased physician concerns about increased scrutiny and legal, regulatory, or administrative sanctions. Despite a disturbing shift in regulatory authority over opioid analgesics away from health agencies and toward law enforcement agencies, recent state policies and guidelines from national medical organizations are playing an important role in promoting the use of opioids for pain treatment and helping to reduce practitioners' concerns over regulatory oversight. Current and future trends concerning the legal and regulatory aspects of chronic opioid treatment are discussed in this article.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17087867     DOI: 10.1007/s11916-006-0073-4

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  17 in total

1.  Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential.

Authors:  L Simoni-Wastila; C Tompkins
Journal:  Subst Use Misuse       Date:  2001 Jul-Aug       Impact factor: 2.164

2.  Providing relief to those in pain: a retrospective on the scholarship and impact of the Mayday Project.

Authors:  Sandra H Johnson
Journal:  J Law Med Ethics       Date:  2003       Impact factor: 1.718

3.  Dear DEA.

Authors:  Howard A Heit; Edward Covington; Patricia M Good
Journal:  Pain Med       Date:  2004-09       Impact factor: 3.750

4.  Damned if they do, damned if they don't: the need for a comprehensive public policy to address the inadequate management of pain.

Authors:  Amy J Dilcher
Journal:  Ann Health Law       Date:  2004

5.  Pain and politics: DEA, Congress, and the courts, oh my!

Authors:  Scott M Fishman
Journal:  Pain Med       Date:  2006 Jan-Feb       Impact factor: 3.750

6.  DEA and Schedule II "do not fill prescriptions"--disappointing enforcement activity.

Authors:  Jennifer Bolen
Journal:  Pain Med       Date:  2006 Jan-Feb       Impact factor: 3.750

7.  Prescription pain medications: frequently asked questions and answers for health care professionals, and law enforcement personnel.

Authors: 
Journal:  J Pain Palliat Care Pharmacother       Date:  2005

Review 8.  The truth about pain management: the difference between a pain patient and an addicted patient.

Authors:  H A Heit
Journal:  Eur J Pain       Date:  2001       Impact factor: 3.931

9.  The risk of disciplinary action by state medical boards against physicians prescribing opioids.

Authors:  Jack Richard; Marcus M Reidenberg
Journal:  J Pain Symptom Manage       Date:  2005-02       Impact factor: 3.612

Review 10.  Public policy statement on the rights and responsibilities of health care professionals in the use of opioids for the treatment of pain: a consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine.

Authors: 
Journal:  Pain Med       Date:  2004-09       Impact factor: 3.750

View more
  1 in total

1.  Computerized progress notes for chronic pain patients receiving opioids; the Prescription Opioid Documentation System (PODS).

Authors:  Barth L Wilsey; Scott M Fishman; Carlos Casamalhuapa; Naileshni Singh
Journal:  Pain Med       Date:  2010-11       Impact factor: 3.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.